Urinary Retention on Sertraline: Not Common
Urinary retention is NOT a common side effect of sertraline—it is rare, occurring in approximately 0.025% of patients on selective serotonin reuptake inhibitors (SSRIs) according to systematic review data 1.
Incidence and Evidence
The FDA drug label for sertraline lists "urinary incontinence" as a side effect observed in pediatric patients but does not list urinary retention as a common adverse event in adults 2. In fact, a 1993 review explicitly states that sertraline is "free of cardiac effects; they do not cause hypotension, urinary retention or blurred vision" 3.
Key Data Points:
- Systematic review findings: Among SSRIs, urinary retention occurred in only 0.025% of patients 1
- Comparative context: This is dramatically lower than tricyclic antidepressants (17.6% on imipramine) or certain antipsychotics 1
- Case report literature: Only isolated case reports exist documenting urinary retention with sertraline 4, 5
Clinical Presentation When It Does Occur
When urinary retention develops with sertraline (rare), it typically:
- Shows a temporal relationship to drug initiation or dose increase 4
- Resolves with discontinuation or dose reduction 4, 1
- May be potentiated by concomitant anticholinergic medications (e.g., dimenhydrinate) 5
Important Caveat:
Urinary incontinence (not retention) appears more commonly with sertraline, particularly in pediatric patients and elderly women 2, 6. A recent case documented dose-dependent urinary incontinence in a 73-year-old woman that improved with dose reduction 6.
Mechanism and Risk Factors
Serotonergic neurons are involved in lower urinary tract control at multiple levels 4. However, unlike tricyclic antidepressants or SNRIs which have significant anticholinergic or noradrenergic effects, sertraline's selective serotonin reuptake inhibition rarely affects bladder emptying 3, 7.
Higher Risk Scenarios:
- Combination with alpha-blockers (e.g., terazosin, prazosin, doxazosin) - though this interaction is documented with midodrine, not sertraline specifically 8
- Elderly patients with pre-existing voiding dysfunction
- Concomitant anticholinergic medications 5
Clinical Management
If urinary retention develops in a patient on sertraline:
- Confirm temporal relationship - Did symptoms begin after starting sertraline or increasing dose?
- Review all medications - Look for additive anticholinergic effects from other drugs
- Consider dose reduction first - Many cases resolve with lower doses 4
- Discontinue if persistent - Complete symptom resolution typically occurs within 48 hours 4, 5
- Rule out other causes - Urological evaluation if symptoms persist after drug discontinuation
Bottom line: While clinicians should maintain awareness of this potential adverse effect, urinary retention should not be a primary concern when prescribing sertraline, as it occurs in fewer than 1 in 4,000 patients. The more common urinary side effect is incontinence, particularly in vulnerable populations 2, 6, 7.